Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Pharma Holdings ( (CPHI) ) has shared an update.
On April 4, 2025, China Pharma Holdings announced a 1-for-10 reverse stock split set to take effect on April 15, 2025. This move, authorized by the Board and stockholders, will consolidate every 10 shares into one, affecting all shareholders uniformly without altering their percentage interest in the company.
More about China Pharma Holdings
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets a diverse range of products targeting high-incidence and high-mortality conditions in China, such as cardiovascular, CNS, infectious, and digestive diseases. The company operates a cost-effective business model driven by market demand, supported by GMP-certified product lines, and has a broad distribution network across major Chinese cities and provinces.
YTD Price Performance: -0.83%
Average Trading Volume: 1,090,961
Technical Sentiment Signal: Buy
Current Market Cap: $7.79M
Learn more about CPHI stock on TipRanks’ Stock Analysis page.